Canada's prime minister issued a statement on U.S. plans to impose additional tariffs.

On July 21 a Shanghai Sci‑Tech Innovation Fund portfolio company, Zhuhai Tainuo Maibo Pharmaceutical, listed on the STAR Market, raising the fund's portfolio IPO count to 228. The fund targets 30 bln yuan and currently manages more than 20 bln yuan. It has invested in over 100 sub‑funds and has signed sub‑fund commitments of roughly 300 bln yuan. The portfolio includes over 3,000 companies, 228 listed firms (95 on the STAR Market) and more than 780 national-level specialized and innovative "little giant" enterprises.

Newly listed stock N Tainuo-U jumped 246.82% at the open; its prospectus says the company develops blood-product substitute therapies.